[ Price : $8.95]
Biogen wins a fast-track designation for BIIB080, an investigational antisense oligonucleotide therapy for treating Alzheimers dis...[ Price : $8.95]
Former FDA commissioner Mark McClellan says it will be a challenge for the agency to come through the massive reorganization and s...[ Price : $8.95]
Industry associations sound alarms and frustrations as they weigh how FDA staff cuts will impact product development, FDA reviews ...[ Price : $8.95]
Roche says the Phase 3 MUSETTE study found that a higher dose of Ocrevus IV did not provide more benefit than the approved 600 mg ...[ Price : $8.95]
Edgewise Therapeutics says its EDG-7500 achieved positive results in the four-week CIRRUS-HCM trial in hypertrophic cardiomyopathy...[ Price : $8.95]
The Senate HELP Committee invites HHS secretary RFK, Jr., to testify on his reorganization of the department.[ Price : $8.95]
FDA misses its 4/1 user fee review action target date on a Novavax BLA seeking full approval for its current Covid-19 vaccine.[ Price : $8.95]
FDA says it is reprioritizing planned inspections for the rest of the year due to challenges it faces after 170 administrative and...